|Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia.
|International Clinical Psychopharmacology
|Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis
|Optimal dose of brexpiprazole for augmentation therapy of antidepressant-refractory depression: a systematic review and dose-effect meta-analysis.
|Psychiatry and Clinical Neurosciences
|Efficacy and safety of adjunctive serotonin-dopamine activity modulators in major depression: a meta-analysis of randomized controlled trials.
|Journal of Clinical Pharmacology
|Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis.
|Journal of Affective Disorders
|Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials.
|The Journal of Psychoses and Related Disorders
|Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.
|Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis
|Efficacy and safety of antipsychotic treatments for schizophrenia: a systematic review and network meta-analysis of randomized trials in Japan.
|Journal of Psychiatric Research
|Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
|Journal of psychopharmacology
|Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan
|Journal of psychiatric research
|Blonanserin patch vs. other antipsychotics for acute schizophrenia: a systematic review of double-blind, randomized, placebo-controlled, phase 3 trials in Japan.
|Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.
|Brexpiprazole as adjunctive treatment for major depressive disorder following treatment failure with at least one antidepressant in the current episode: a systematic review and meta-analysis.
|International Journal of Neuropsychopharmacology
|Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.
|Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
|Australian public assessment report for brexpiprazole.
|Australian Government: Department of Health
|Assessment report: Rexulti.
|Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials.
|Neuropsychiatric Disease and Treatment
|Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
|Neuropsychiatric disease and treatment